PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
Valentine W, Massi-Benedetti M, Tan M, Yates J, Dormandy J, Williams R, Foos V, Brändle M, Palmer A, Bottomley J, PROactive Study Group. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002.
01.09.2007
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
01.09.2007
Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002
Valentine W J, Massi-Benedetti M, Tan M H, Yates J, Dormandy J A, Williams R, Foos V, Brändle Michael, Palmer A J, Bottomley J M, PROactive Study Group
Weiter
